Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Recurso digital |
| Jezik: | |
| Izdano: |
Zenodo
2025
|
| Teme: | |
| Online pristup: | https://doi.org/10.5281/zenodo.17676363 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Sadržaj:
- Ticagrelor monotherapy following short-term DAPT seems effective in reducing bleeding risk without increasing ischemic events in ACS patients post-PCI, but further research is necessary to fully validate its use outside of controlled trial settings.